M&T Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263K | Buy |
7,232
+1,192
| +20% | +$43.4K | ﹤0.01% | 1325 |
|
|
2025
Q1 | $219K | Sell |
6,040
-403
| -6% | -$14.6K | ﹤0.01% | 1384 |
|
|
2024
Q4 | $271K | Sell |
6,443
-549
| -8% | -$23.1K | ﹤0.01% | 1430 |
|
|
2024
Q3 | $388K | Buy |
6,992
+525
| +8% | +$29.2K | ﹤0.01% | 1256 |
|
|
2024
Q2 | $265K | Sell |
6,467
-68
| -1% | -$2.79K | ﹤0.01% | 1363 |
|
|
2024
Q1 | $306K | Buy |
6,535
+49
| +0.8% | +$2.29K | ﹤0.01% | 1316 |
|
|
2023
Q4 | $310K | Buy |
+6,486
| New | +$310K | ﹤0.01% | 1302 |
|
|
2023
Q3 | – | Sell |
-4,474
| Closed | -$206K | – | 1590 |
|
|
2023
Q2 | $206K | Buy |
+4,474
| New | +$206K | ﹤0.01% | 1464 |
|
|
2023
Q1 | – | Sell |
-4,497
| Closed | -$209K | – | 1625 |
|
|
2022
Q4 | $209K | Buy |
+4,497
| New | +$209K | ﹤0.01% | 1460 |
|
|
2015
Q3 | – | Sell |
-2,694
| Closed | -$276K | – | 1879 |
|
|
2015
Q2 | $276K | Buy |
+2,694
| New | +$276K | ﹤0.01% | 1539 |
|